It has been demonstrated that extracellular GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or its N-terminal domain can inhibit the growth of GC cells [45], and the negative regulation of tumor growth with GAPDH may be a new anti-cancer strategy [46]. This evidence concerns the gene GAPDH and neoplasm.